208 related articles for article (PubMed ID: 11200206)
1. The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonates.
Hamdy NA; Papapoulos SE
Semin Nucl Med; 2001 Jan; 31(1):62-8. PubMed ID: 11200206
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the management of prostate carcinoma metastatic to the skeleton.
Papapoulos SE; Hamdy NA; van der Pluijm G
Cancer; 2000 Jun; 88(12 Suppl):3047-53. PubMed ID: 10898350
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
4. Strategies for management of prostate cancer-related bone pain.
Pelger RC; Soerdjbalie-Maikoe V; Hamdy NA
Drugs Aging; 2001; 18(12):899-911. PubMed ID: 11888345
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for advanced prostate cancer.
Yuen KK; Shelley M; Sze WM; Wilt T; Mason MD
Cochrane Database Syst Rev; 2006 Oct; (4):CD006250. PubMed ID: 17054286
[TBL] [Abstract][Full Text] [Related]
6. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
7. The use of bisphosphonates in the management of bone metastatic prostate cancer.
Mercadante S
Curr Urol Rep; 2002 Jun; 3(3):244-9. PubMed ID: 12084196
[TBL] [Abstract][Full Text] [Related]
8. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and radiation therapy for palliation of metastatic bone disease.
Hoskin PJ
Cancer Treat Rev; 2003 Aug; 29(4):321-7. PubMed ID: 12927572
[TBL] [Abstract][Full Text] [Related]
11. The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases.
Tomblyn M
Cancer Control; 2012 Apr; 19(2):137-44. PubMed ID: 22487976
[TBL] [Abstract][Full Text] [Related]
12. [The effect of bisphosphonates on bone metastasis of hormone-refractory prostate cancer].
Tanaka T; Kawashima H; Kuratsukuri K; Sugimura K; Nakatani T
Hinyokika Kiyo; 2006 Jun; 52(6):491-4. PubMed ID: 16848364
[TBL] [Abstract][Full Text] [Related]
13. The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.
Saad F; Higano CS; Sartor O; Colombel M; Murray R; Mason MD; Tubaro A; Schulman C
Clin Genitourin Cancer; 2006 Mar; 4(4):257-62. PubMed ID: 16729908
[TBL] [Abstract][Full Text] [Related]
14. Natural history and treatment of bone complications in prostate cancer.
Saad F; Clarke N; Colombel M
Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment.
Eaton CL; Coleman RE
Cancer Treat Rev; 2003 Jun; 29(3):189-98. PubMed ID: 12787713
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates in the management of metastatic prostate cancer.
Heidenreich A
Oncology; 2003; 65 Suppl 1():5-11. PubMed ID: 12949427
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
18. Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies.
Saad F; Colombel M
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1991-2002. PubMed ID: 21110764
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
20. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
